EDGAR Filing Documents for 0001753926-23-001389

Form 8-K - Current report:

SEC Accession No. 0001753926-23-001389

Filing Date

2023-10-26

Accepted

2023-10-25 18:30:05

Documents

Period of Report

2023-10-23

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	g083821_8k.htm iXBRL	8-K	47488
2	EXHIBIT 4.1	g083821_ex4-1.htm	EX-4.1	111449
3	EXHIBIT 4.2	g083821_ex4-2.htm	EX-4.2	99357
4	EXHIBIT 4.3	g083821_ex4-3.htm	EX-4.3	115147
5	EXHIBIT 10.1	g083821_ex10-1.htm	EX-10.1	276443
6	EXHIBIT 10.2	g083821_ex10-2.htm	EX-10.2	175488
7	EXHIBIT 99.1	g083821_ex99-1.htm	EX-99.1	16178
8	EXHIBIT 99.2	g083821_ex99-2.htm	EX-99.1	14314
	Complete submission text file	0001753926-23-001389.txt		1215328

Data Files

Seq	Description	Document	Type	Size
9	XBRL SCHEMA FILE	lipo-20231023.xsd	EX-101.SCH	3012
10	XBRL LABEL FILE	lipo-20231023_lab.xml	EX-101.LAB	34240
11	XBRL PRESENTATION FILE	lipo-20231023_pre.xml	EX-101.PRE	22357
13	EXTRACTED XBRL INSTANCE DOCUMENT	g083821_8k_htm.xml	XML	3473

Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208

Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315

LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)